"Kidney Stone Disease in 2025: Something Old, Something New, Something Borrowed, Something Bluetooth"

Speaker:

Naim Maalouf, M.D.
Professor of Internal Medicine
Division of Endocrinology
Associate Director, Charles and Jane Pak Center for Mineral Metabolism and Clinical Research
UT Southwestern Medical Center

About Naim Maalouf:

Dr. Maalouf holds a bachelor's degree in chemistry from the American University of Beirut, where he also earned his medical degree. He completed internal medicine residency training at Emory University in Atlanta, followed by advanced training through an endocrinology and metabolism fellowship at UT Southwestern.

Dr. Maalouf joined the UT Southwestern faculty in 2004.

Dr. Maalouf’s research spans the pathophysiology, prevention, and treatment of kidney stone disease, with a focus on calcium phosphate, calcium oxalate, and uric acid stones. He investigates novel therapies such as hydroxycitrate, the metabolic and dietary contributors to stone formation—including protein intake, obesity, and weight loss—and the development of advanced methods to monitor stone progression. His work also includes optimizing fluid therapy and stent management in both adults and children with nephrolithiasis. Beyond kidney stones, Dr. Maalouf explores broader metabolic and systemic health issues, including the effects of reversing hyperuricemia on metabolic syndrome, the role of renal lipotoxicity in uric acid stone formation, vitamin D’s relationship with type 2 diabetes, the determinants of bone health in HIV-infected individuals and people with cystic fibrosis, and complications of primary hyperparathyroidism, reflecting a comprehensive interest in mineral metabolism and endocrine-related disorders.